| dbo:abstract
|
- Vyera Pharmaceuticals (formerly Turing Pharmaceuticals) is a pharmaceutical company incorporated in Zug, Switzerland, with offices in New York City. The company started to do business in the US as Vyera Pharmaceuticals in September 2017. The company has two marketed products: Daraprim (pyrimethamine), for the treatment of toxoplasmosis, and Vecamyl (mecamylamine hydrochloride) for the treatment of hypertension. The company was widely criticized for raising the price of daraprim by 5456% following its acquisition of rights to the drug in 2015. After the price raise of the drug, the company's stocks dropped around 10%. CEO Martin Shkreli faced immense criticism for his actions. The company was named after Alan Turing, the computer scientist. (en)
- Turing Pharmaceuticals — фармацевтическая компания, реализующая два продукта: Daraprim (пириметамин) для лечения токсоплазмоза и Vecamyl (мекамиламина гидрохлорид) для лечения гипертонической болезни. Компания подверглась широкой критике за повышение цен на Daraprim более чем на 5000 % после того, как приобрела права на препарат в 2015 году. Компания названа в честь британского математика Алана Тьюринга. (ru)
|
| dbo:foundedBy
| |
| dbo:industry
| |
| dbo:keyPerson
| |
| dbo:location
| |
| dbo:thumbnail
| |
| dbo:type
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 12944 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:founder
| |
| dbp:industry
| |
| dbp:keyPeople
|
- Justin Garrett (en)
- (Chief Executive Officer) (en)
|
| dbp:location
|
- New York City and Zug, Switzerland (en)
|
| dbp:logo
| |
| dbp:name
|
- Vyera Pharmaceuticals (en)
|
| dbp:products
| |
| dbp:type
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- Turing Pharmaceuticals — фармацевтическая компания, реализующая два продукта: Daraprim (пириметамин) для лечения токсоплазмоза и Vecamyl (мекамиламина гидрохлорид) для лечения гипертонической болезни. Компания подверглась широкой критике за повышение цен на Daraprim более чем на 5000 % после того, как приобрела права на препарат в 2015 году. Компания названа в честь британского математика Алана Тьюринга. (ru)
- Vyera Pharmaceuticals (formerly Turing Pharmaceuticals) is a pharmaceutical company incorporated in Zug, Switzerland, with offices in New York City. The company started to do business in the US as Vyera Pharmaceuticals in September 2017. (en)
|
| rdfs:label
|
- Turing Pharmaceuticals (ru)
- Vyera Pharmaceuticals (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Vyera Pharmaceuticals (en)
|
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
